OCD Trial, Recruiting NCT07103902 Sponsor: Yale University Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT07103902
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between the ages of 18 and 64 years old
  • People who have been diagnosed with OCD (Obsessive-Compulsive Disorder), confirmed using a specific diagnostic interview called the DIAMOND
  • People who are either not currently receiving any psychiatric treatment or medication, or whose psychiatric treatment or medication has been stable for at least 4 weeks (medications will be reviewed by the study's psychiatrist on a case-by-case basis)

Who may not be able to join:

  • People who have an active or poorly controlled psychotic disorder, a pervasive developmental disorder (such as autism spectrum disorder), bipolar disorder, a moderate-to-severe current substance use disorder, or who have had suicidal intent, a plan, or a suicide attempt within the past 3 months
  • People who have documented physical or movement difficulties, or a medical condition, that would prevent them from taking part in physical exercise
  • People who are currently pregnant or trying to become pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 203-858-1225

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
16 February 2026
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Cognitive flexibility will be assessed using a probabilistic reversal learning (PRL) task called the Lucky Picture Selection Game.; Symptom reactivity will be assessed using the Braga Obsessive Compulsive Symptom Image Set (BOCI).; Exercise intensity will be measured using a PolarTech chest-strap HR monitor.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov